Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Occupational therapy in India: focus on functional recovery and need for empowerment.

Samuel R, Jacob KS.

Indian J Psychiatry. 2017 Apr-Jun;59(2):242-246. doi: 10.4103/psychiatry.IndianJPsychiatry_111_17.

2.

Aerobic Exercise in People with Schizophrenia: Neural and Neurocognitive Benefits.

Vakhrusheva J, Marino B, Stroup TS, Kimhy D.

Curr Behav Neurosci Rep. 2016 Jun;3(2):165-175. Epub 2016 Apr 4.

3.

Current understandings about cognition and the neurobiological correlates in schizophrenia.

Kar SK, Jain M.

J Neurosci Rural Pract. 2016 Jul-Sep;7(3):412-8. doi: 10.4103/0976-3147.176185. Review.

4.

Insight and subjective measures of quality of life in chronic schizophrenia.

Siu CO, Harvey PD, Agid O, Waye M, Brambilla C, Choi WK, Remington G.

Schizophr Res Cogn. 2015 Sep 1;2(3):127-132. Epub 2015 Jun 9.

5.

Depressive Symptoms, Cognition, and Everyday Function Among Community-Residing Older Adults.

Brewster GS, Peterson L, Roker R, Ellis ML, Edwards JD.

J Aging Health. 2017 Apr;29(3):367-388. doi: 10.1177/0898264316635587. Epub 2016 Jul 9.

PMID:
26951519
6.

Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses.

Bortolato B, Miskowiak KW, Köhler CA, Vieta E, Carvalho AF.

Neuropsychiatr Dis Treat. 2015 Dec 17;11:3111-25. doi: 10.2147/NDT.S76700. eCollection 2015. Review.

7.

Re-conceptualizing ASD Within a Dimensional Framework: Positive, Negative, and Cognitive Feature Clusters.

Foss-Feig JH, McPartland JC, Anticevic A, Wolf J.

J Autism Dev Disord. 2016 Jan;46(1):342-51. doi: 10.1007/s10803-015-2539-x.

8.

Longitudinal relations between symptoms, neurocognition, and self-concept in schizophrenia.

Hesse K, Kriston L, Wittorf A, Herrlich J, Wölwer W, Klingberg S.

Front Psychol. 2015 Jul 3;6:917. doi: 10.3389/fpsyg.2015.00917. eCollection 2015.

9.

An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia.

Shiina A, Kanahara N, Sasaki T, Oda Y, Hashimoto T, Hasegawa T, Yoshida T, Iyo M, Hashimoto K.

Clin Psychopharmacol Neurosci. 2015 Apr 30;13(1):62-7. doi: 10.9758/cpn.2015.13.1.62.

10.

Developing treatments for cognitive deficits in schizophrenia: the challenge of translation.

Young JW, Geyer MA.

J Psychopharmacol. 2015 Feb;29(2):178-96. doi: 10.1177/0269881114555252. Epub 2014 Dec 16. Review.

11.

Meta-analysis of studies in China about changes in P300 latency and amplitude that occur in patients with schizophrenia during treatment with antipsychotic medication.

Su L, Cai Y, Shi S, Wang L.

Shanghai Arch Psychiatry. 2012 Aug;24(4):200-7. doi: 10.3969/j.issn.1002-0829.2012.04.004.

12.

Cognition in schizophrenia: Past, present, and future.

Green MF, Harvey PD.

Schizophr Res Cogn. 2014 Mar;1(1):e1-e9.

13.

Antidepressants for cognitive impairment in schizophrenia--a systematic review and meta-analysis.

Vernon JA, Grudnikoff E, Seidman AJ, Frazier TW, Vemulapalli MS, Pareek P, Goldberg TE, Kane JM, Correll CU.

Schizophr Res. 2014 Nov;159(2-3):385-94. doi: 10.1016/j.schres.2014.08.015. Epub 2014 Sep 18. Review.

14.

Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial.

Pagsberg AK, Jeppesen P, Klauber DG, Jensen KG, Rudå D, Stentebjerg-Olesen M, Jantzen P, Rasmussen S, Saldeen EA, Lauritsen MB, Bilenberg N, Stenstrøm AD, Pedersen J, Nyvang L, Madsen S, Lauritsen MB, Vernal DL, Thomsen PH, Paludan J, Werge TM, Winge K, Juul K, Gluud C, Skoog M, Wetterslev J, Jepsen JR, Correll CU, Fink-Jensen A, Fagerlund B.

BMC Psychiatry. 2014 Jul 11;14:199. doi: 10.1186/1471-244X-14-199.

15.

Neural Substrates of Dopamine D2 Receptor Modulated Executive Functions in the Monkey Prefrontal Cortex.

Puig MV, Miller EK.

Cereb Cortex. 2015 Sep;25(9):2980-7. doi: 10.1093/cercor/bhu096. Epub 2014 May 9.

16.

Development of a virtual reality assessment of everyday living skills.

Ruse SA, Davis VG, Atkins AS, Krishnan KR, Fox KH, Harvey PD, Keefe RS.

J Vis Exp. 2014 Apr 23;(86). doi: 10.3791/51405.

17.

Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone.

Hori H, Yamada K, Kamada D, Shibata Y, Katsuki A, Yoshimura R, Nakamura J.

Neuropsychiatr Dis Treat. 2014 Mar 26;10:527-33. doi: 10.2147/NDT.S59861. eCollection 2014.

18.

MK-801 Impairs Cognitive Coordination on a Rotating Arena (Carousel) and Contextual Specificity of Hippocampal Immediate-Early Gene Expression in a Rat Model of Psychosis.

Kubík S, Buchtová H, Valeš K, Stuchlík A.

Front Behav Neurosci. 2014 Mar 12;8:75. doi: 10.3389/fnbeh.2014.00075. eCollection 2014.

19.

Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis.

Montalvo I, Gutiérrez-Zotes A, Creus M, Monseny R, Ortega L, Franch J, Lawrie SM, Reynolds RM, Vilella E, Labad J.

PLoS One. 2014 Feb 24;9(2):e89428. doi: 10.1371/journal.pone.0089428. eCollection 2014.

20.

Cognitive training for schizophrenia in developing countries: a pilot trial in Brazil.

Pontes LM, Martins CB, Napolitano IC, Fonseca JR, Oliveira GM, Iso SM, Menezes AK, Vizzotto AD, di Sarno ES, Elkis H.

Schizophr Res Treatment. 2013;2013:321725. doi: 10.1155/2013/321725. Epub 2013 Oct 30.

Supplemental Content

Support Center